No Picture
Trading Ideas

United to drop contract with ExpressJet, dealing potentially fatal blow

United Airlines said on Thursday it has decided to drop its contract with ExpressJet, and consolidate all of its outsourced flying on 50-seat planes with regional rival CommutAir. The decision could be a fatal blow to ExpressJet, which will begin to wind down its operations, according to a memo from Chief Executive Subodh Karnik to employees seen by Reuters. Reuters reported United’s choice between the two carriers on Monday, after it saw a union letter to ExpressJet pilots warning that the choice could have a “dramatic impact” on the future of ExpressJet. …read more […]

No Picture
Trading Ideas

Google ad rebound offsets Alphabet's first-ever sales drop

OAKLAND, Calif./BENGALURU (Reuters) – Google’s ad sales have recovered since plummeting in March during the coronavirus pandemic, parent Alphabet Inc said on Thursday, easing concerns about its first quarterly sales slide in its 16 years as a public company. Alphabet shares were barely changed at $1,552, above their pre-pandemic high, after it said revenue fell 2% in the second quarter, less than analysts’ estimate of a 4% decline. Alphabet, whose ad sales account for about 78% of its revenue, has struggled during past economic slowdowns, as marketing is often the first budget item to get slashed. …read more […]

No Picture
Trading Ideas

Amazon posts biggest profit ever at height of pandemic in U.S

Shares of Amazon, the world’s largest online retailer, rose 5% in after-hours trade. While rival brick-and-mortar retailers have had to shut stores during government-imposed lockdowns, Amazon hired 175,000 people in recent months and saw demand for its services soar. Amazon had forecast it might lose money in the just-ended second quarter because it expected to spend some $4 billion on protective equipment for staff and other expenses related to COVID-19. …read more […]

No Picture
Trading Ideas

Australian dollar poised to break 0.72 US cents

Posted by OFX AUD – Australian Dollar The Australian dollar offered little to excite investors through trade on Thursday, again failing to break above resistance at 0.72 US cents. Risk assets came under pressure overnight as oil prices dipped and President Trump suggested a delay to the Presidential Election in November. Trump’s … Continue reading “Australian dollar poised to break 0.72 US cents”The post Australian dollar poised to break 0.72 US cents appeared first on . …read more […]

No Picture
Trading Ideas

Amazon Plows Through Pandemic With Record Profits

(Bloomberg) — Amazon.com Inc. justified its big investments to keep operating through the Covid-19 pandemic with sales growth and a record profit that far exceeded analysts’ estimates, showing that staying open when so many businesses were forced to close was a rare opportunity.The online retail giant spent more than $4 billion in the second quarter to clean warehouses, hire employees and entice them back to work with temporary pay raises while much of the country shut down. That push paid off as customers shifted from buying groceries and emergency supplies early in the pandemic to bigger orders with electronics and …read more […]

No Picture
Trading Ideas

ImagineAR Announces Mike Anderson, Former MD of The Sun, as Advisor to CEO For Spearheading UK & Europe Sales

VANCOUVER, BC, July 30, 2020 /CNW/ – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create their own mobile phone AR campaigns, is pleased to announce that Mike Anderson has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform sales in the UK and Europe. Mr. Anderson is the former managing director of the The Sun and News of the World publications, and founder of the mobile app UK development company -The Chelsea Apps factory. ImagineAR believes Mr. Anderson will significantly …read more […]

No Picture
Trading Ideas

Did Kodak Tip Us Off to the Tune of 2,000% in a Day?

In case you didn’t notice, on July 27, Eastman Kodak (NYSE: KODK) was trading at $2.50, and it rose to more than $50 yesterday. That type of move doesn’t come by very often. But if you’ve been a War Room member since March, you would have seen this message…

Then in May, you would have seen this…

Rivers made at least four times his money on that play!
“KODK Aug 21 ’20 $7.50 Call; in yesterday at $2.35. out at $11.50… +388%… thx war room.” – Rivers 7/29/2020 at 9:50 a.m.
Look at this chart – it’s parabolic!

Kodak was loaned $765 million by the …read more […]

No Picture
Trading Ideas

7 Biopharmaceutical Companies Finding Success During COVID-19

By CorpGov Editorial Staff The COVID-19 pandemic is both a health and economic crisis for countries around the world. Communities are experiencing loss of lives, businesses, and lifestyles, challenging biopharmaceutical companies to urgently develop therapeutics and vaccines that address this crisis while remaining profitable. Companies are employing diverse strategies to cope with the economic challenges […] …read more […]

No Picture
Trading Ideas

Improve Your Performance With a Coin-Flip Mindset

Would you like to hit more investment home runs while making fewer mistakes?
Who wouldn’t?
One investing superstar can help us do exactly that. He has built a great long-term investment track record using a simple formula designed specifically to…
1. Make fewer investment mistakes
2. Find more investment home runs.
Using this formula, this gentleman has turned into the unicorn of the finance world – a home run hitter who doesn’t strike out.
The beauty of his formula is that you and I can also successfully put it to work. It isn’t rocket science. It’s all about common sense…
20 Years of Outperformance Isn’t a Fluke
For …read more […]

No Picture
Trading Ideas

Moderna’s COVID-19 Vaccine Is Making Good Progress but Valuation Is Too High, Says J.P. Morgan

Moderna (MRNA) is undoubtedly one of 2020’s success stories. Its rise has rested on the hope it can be the one to solve the COVID-19 conundrum and bring to market the desperately needed COVID-19 vaccine.Although several questions regarding its business practices – unrelated to its vaccine candidate’s progress – have come to the fore recently (including how execs are possibly profiteering off the stock’s rise and an unsuccessful attempt to invalidate another company’s patent), what concerns J.P. Morgan analyst Cory Kasimov at this point, is its fast accumulation of share gains.“Bigger picture,” said the 5-star analyst, “We remain …read more […]